X4 Pharmaceuticals, Inc. - Common Stock (NQ:XFOR)

2.755 -0.145 (-5.00%)

Delayed Quote Updated: 3:22 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about X4 Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Why Horizon Therapeutics Shares Are Trading Higher By Over 30%; Here Are 32 Stocks Moving Premarket ↗

November 30, 2022

Gainers Kalera Public Limited Company (NASDAQ: KAL) shares rose 33.3% to $0.2399 in pre-market trading after jumping 45% on Tuesday. Kalera recently announced restructuring process for German...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 29, 2022

Via Benzinga

X4 Pharmaceuticals: Q3 Earnings Insights ↗

November 03, 2022

X4 Pharmaceuticals (NASDAQ:XFOR) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:05 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session ↗

September 30, 2022

Gainers

Via Benzinga

Earnings Scheduled For November 3, 2022 ↗

November 03, 2022

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

Via Benzinga

Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday ↗

October 03, 2022

Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37.

Via Benzinga

X4 Pharma Highlights New Data Supporting Mavorixafor's Broad Potential In Chronic Neutropenia ↗

September 27, 2022

Via Benzinga

X4 Pharmaceuticals: Q2 Earnings Insights ↗

August 04, 2022

X4 Pharmaceuticals (NASDAQ:XFOR) reported its Q2 earnings results on Thursday, August 4, 2022. Here's what investors need to know about the announcement.

Via Benzinga

X4 Pharma To Stop Further Work On Oncology Programs, Looks For Partner(s) ↗

July 21, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

September 30, 2022

Good morning, investor! We're closing out the trading week with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday ↗

September 28, 2022

Gainers

Via Benzinga

Recap: X4 Pharmaceuticals Q1 Earnings ↗

May 12, 2022

X4 Pharmaceuticals (NASDAQ:XFOR) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 26, 2022

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 27, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 19, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 02, 2022

Gainers Applied DNA Sciences (NASDAQ:APDN) stock rose 90.0% to $5.32 during Tuesday's after-market session. At the close, Applied DNA Sciences's trading volume reached 28.8 million shares. This is...

Via Benzinga

Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners ↗

July 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact ↗

July 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 30, 2022

On Thursday, 588 stocks hit new 52-week lows.

Via Benzinga

25 Stocks Moving in Tuesday's Pre-Market Session ↗

May 24, 2022

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 136.4% to $1.43 in pre-market trading. BOQI International recently posted a Q1 loss of $0.27 per share.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 27, 2022

During Monday's session, 77 companies made new 52-week lows.

Via Benzinga

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More ↗

May 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

71 Biggest Movers From Yesterday ↗

May 25, 2022

Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 11, 2022

Gainers

Via Benzinga

50 Stocks Moving In Tuesday's Mid-Day Session ↗

May 24, 2022

Gainers CynergisTek, Inc. (NYSE: CTEK) jumped 100% to $1.18 after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million.

Via Benzinga

X4 Pharmaceuticals's Earnings Outlook ↗

May 11, 2022

X4 Pharmaceuticals (NASDAQ:XFOR) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that X4...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 20, 2022

Gainers

Via Benzinga

Earnings Scheduled For May 12, 2022 ↗

May 12, 2022

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 04, 2022

During Wednesday's trading, 435 companies set new 52-week lows.

Via Benzinga

The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data ↗

March 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.